SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr. Reddy's relaunches Esomeprazole Magnesium Delayed-Release Capsules, USP

30 Dec 2015 Evaluate

Dr. Reddy’s Laboratories has relaunched its Esomeprazole Magnesium Delayed-Release Capsules, a therapeutic equivalent generic version of Nexium (esomeprazole magnesium) Delayed-Release capsules in the US market. The re-launch is due to a change in the capsule color. Nexium is a registered trademark of Astrazeneca AB Corporation.

Dr. Reddy's Laboratories, is a multinational pharmaceutical company based in Hyderabad, Telangana, India. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Labs. Share Price

1166.50 -16.50 (-1.39%)
23-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1954.05
Dr. Reddys Labs. 1166.50
Cipla 1393.75
Lupin 2396.00
Zydus Lifesciences 1113.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: